Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$160.99 - $215.69 $1.2 Million - $1.61 Million
-7,458 Reduced 87.38%
1,077 $205,000
Q3 2023

Nov 14, 2023

BUY
$194.33 - $283.97 $774,405 - $1.13 Million
3,985 Added 87.58%
8,535 $1.7 Million
Q2 2023

Aug 14, 2023

BUY
$223.05 - $302.68 $1.01 Million - $1.38 Million
4,550 New
4,550 $1.3 Million
Q4 2022

Feb 14, 2023

BUY
$204.38 - $296.82 $895,593 - $1.3 Million
4,382 New
4,382 $900,000
Q1 2022

May 16, 2022

SELL
$127.96 - $207.36 $239,413 - $387,970
-1,871 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$165.13 - $241.83 $76,290 - $111,725
462 Added 32.79%
1,871 $334,000
Q3 2021

Nov 15, 2021

BUY
$163.99 - $235.57 $231,061 - $331,918
1,409 New
1,409 $290,000

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Y Intercept (Hong Kong) LTD Portfolio

Follow Y Intercept (Hong Kong) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.